WINNERS & LOSERS: Allergy Therapeutics shares plunge on AIM exit plan
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More
| Price | 8.80p on 11-11-2026 at 19:35:10 |
|---|---|
| Change | -0.25p -2.76% |
| Buy | 8.89p |
| Sell | 8.70p |
| Last Trade: | Sell 75,000.00 at 9.05p |
| Day's Volume: | 1,526,012 |
| Last Close: | 8.80p |
| Open: | 9.20p |
| ISIN: | GB0008025412 |
| Day's Range | 8.70p - 9.20p |
| 52wk Range: | 6.72p - 10.70p |
| Market Capitalisation: | £101.71m |
| VWAP: | 9.09381p |
| Shares in Issue: | 1.16b |
SIG (SHI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 75,000 | 9.05p | Negotiated Trade |
16:38:29 - 11-Nov-26 |
| Unknown* | -75,000 | 9.05p | Correction Negotiated Trade |
16:38:28 - 11-Nov-26 |
| Sell* | 75,000 | 9.05p | Negotiated Trade |
16:38:28 - 11-Nov-26 |
| Sell* | 2,500 | 8.80p | Automatic Execution |
16:36:57 - 11-Nov-26 |
| Buy* | 682 | 8.88p | SI Trade |
16:29:29 - 11-Nov-26 |
| Buy* | 5,658 | 8.6872p | Ordinary |
16:28:59 - 11-Nov-26 |
| Buy* | 682 | 8.80p | SI Trade |
16:28:59 - 11-Nov-26 |
| Buy* | 3,436 | 8.70p | Automatic Execution |
16:28:59 - 11-Nov-26 |
| Buy* | 613 | 8.80p | SI Trade |
16:28:58 - 11-Nov-26 |
| Sell* | 250,000 | 8.80p | Automatic Execution |
16:28:58 - 11-Nov-26 |
SIG (SHI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Oct 2026 3:31 pm | RNS | Director/PDMR Shareholding |
| 21st Oct 2026 7:00 am | RNS | NED & Chair of Audit & Risk Committee Appointment |
| 14th Oct 2026 4:08 pm | RNS | Director/PDMR Shareholding |
| 9th Oct 2026 7:00 am | RNS | Chief Executive succession |
| 5th Oct 2026 3:51 pm | RNS | Director/PDMR Shareholding |
| 17th Aug 2026 4:19 pm | RNS | Holding(s) in Company |
| 6th Aug 2026 4:30 pm | RNS | Holding(s) in Company |
| 4th Aug 2026 7:00 am | RNS | Results for the six months to 30 June 2026 |
| 16th Jul 2026 7:08 am | RNS | Post-close Trading Update |
| 8th Jun 2026 4:44 pm | RNS | Director/PDMR Shareholding |